Brief: Black Diamond Therapeutics Announces Strategic Priorities And Expected Milestones For 2022
10/01/2022 12:19
Jan 10 (Reuters) - Black Diamond Therapeutics Inc BDTX.O :
* BLACK DIAMOND THERAPEUTICS ANNOUNCES STRATEGIC PRIORITIES AND EXPECTED
MILESTONES FOR 2022
* BLACK DIAMOND THERAPEUTICS INC - ANTICIPATES INITIATION OF IND-ENABLING
STUDIES
FOR ITS CNS-PENETRANT CLASS I,II,III BRAF PROGRAM IN 2022
* BLACK DIAMOND THERAPEUTICS INC - CASH RUNWAY EXTENDED TO 2024
Source text for Eikon: ID:nGNX1dvYMr
Further company coverage: BDTX.O
Recent news on Black Diamond Therapeutics
See all newsBlack Diamond Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Black Diamond Therapeutics Q2 net loss narrows year over year
Black Diamond Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Black Diamond Therapeutics Q4 net loss narrows, full-year profit turns positive
U.S. STOCKS ON THE MOVE-Spirit AeroSystems, Boeing, Roblox